The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
The role of the E6-p53 interaction in the molecular pathogenesis of HPV
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,935
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
T antigen is bound to a host protein in SY40-transformed cells
LANE, D. P., & CRAWFORD, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,394
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,813
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., & Hausen, H. Z. (1985) · Nature · doi:10.1038/314111a0 · Cited by 1,483
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465 · cited 1×
“Transformed cells expressing HPV-16 or HPV-18 E6 lose the G1 checkpoint activity very early, presumably due to the degradation of p53 (Dulic et al., 1994), and are also resistant to p53-induced growth arrest and apoptosis as a result of DNA damage (Kessis et al., 1993; Foster et al., 1994; Pan and…”
BackgroundTHE UBIQUITIN SYSTEM FOR PROTEIN DEGRADATION
Hershko, A., & Ciechanover, A. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.003553 · Cited by 1,410
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206 · cited 1×
“In addition, HPV-16 E6 has been shown to speci®cally upregulate telomerase activity during immortalization (Klingelhutz et al., 1996; StoÈ ppler et al., 1997; Filatov et al., 1998; Kiyono et al., 1998).”
BackgroundStott, F. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5001 · Cited by 1,167
Reed, J. C. (1998) · Oncogene · doi:10.1038/sj.onc.1202591 · Cited by 1,049
A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase.
Huibregtse, J. M., Scheffner, M., Beaudenon, S., & Howley, P. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2563 · Cited by 1,013
Structural basis for the binding of proline-rich peptides to SH3 domains
Yu, H., Chen, J. K., Feng, S., Dalgarno, D. C., Brauer, A. W., & Schrelber, S. L. (1994) · Cell · doi:10.1016/0092-8674(94)90367-0 · Cited by 1,001
Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer
Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G., & Banks, L. (1998) · Nature · doi:10.1038/30400 · Cited by 974
Self-citationFunctional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
Kamijo, T., Weber, J. D., Zambetti, G., Zindy, F., Roussel, M. F., & Sherr, C. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8292 · Cited by 899
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04990.x · Cited by 879
The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines.
Scheffner, M., Münger, K., Byrne, J. C., & Howley, P. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5523 · Cited by 849
Human papillomaviruses in the pathogenesis of anogenital cancer
zur Hausen, H. (1991) · Virology · doi:10.1016/0042-6822(91)90816-t · Cited by 847
Sarnow, P., Ho, Y. S., Williams, J., & Levine, A. J. (1982) · Cell · doi:10.1016/0092-8674(82)90356-7 · Cited by 836
Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53
Honda, R., & Yasuda, H. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.22 · Cited by 724
Two Polymorphic Variants of Wild-Type p53 Differ Biochemically and Biologically
Thomas, M., Kalita, A., Labrecque, S., Pim, D., Banks, L., & Matlashewski, G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1092 · Cited by 701
Self-citationSmotkin, D., & Wettstein, F. O. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4680 · Cited by 661
Telomerase activation by the E6 gene product of human papillomavirus type 16
Klingelhutz, A. J., Foster, S. A., & McDougall, J. K. (1996) · Nature · doi:10.1038/380079a0 · Cited by 660
Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
Kessis, T. D., Slebos, R. J., Nelson, W. G., Kastan, M. B., Plunkett, B. S., Han, S. M., Lorincz, A. T., Hedrick, L., & Cho, K. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.3988 · Cited by 526
Crook, T., Vousden, K. H., & Tidy, J. A. (1991) · Cell · doi:10.1016/0092-8674(91)90529-8 · Cited by 505
Primary structure polymorphism at amino acid residue 72 of human p53.
Matlashewski, G. J., Tuck, S., Pim, D., Lamb, P., Schneider, J., & Crawford, L. V. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.961 · Cited by 497
Self-citationBernard, H.-U., Chan, S.-Y., Manos, M. M., Ong, C.-K., Villa, L. L., Delius, H., Peyton, C. L., Bauer, H. M., & Wheeler, C. M. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/170.5.1077 · Cited by 479
Identification of a novel p53 functional domain that is necessary for efficient growth suppression
Walker, K. K., & Levine, A. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15335 · Cited by 471
Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max
Amati, B., Dalton, S., Brooks, M. W., Littlewood, T. D., Evan, G. I., & Land, H. (1992) · Nature · doi:10.1038/359423a0 · Cited by 460
Myc and Max proteins possess distinct transcriptional activities
Kretzner, L., Blackwood, E. M., & Eisenman, R. N. (1992) · Nature · doi:10.1038/359426a0 · Cited by 453
Schneider-Gädicke, A., & Schwarz, E. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04496.x · Cited by 433
Kiyono, T., Hiraiwa, A., Fujita, M., Hayashi, Y., Akiyama, T., & Ishibashi, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11612 · Cited by 428
Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective
Yamada, T., Manos, M. M., Peto, J., Greer, C. E., Munoz, N., Bosch, F. X., & Wheeler, C. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.2463-2472.1997 · Cited by 421
Woods, D. F., Hough, C., Peel, D., Callaini, G., & Bryant, P. J. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.6.1469 · Cited by 417
Pietenpol, J. A., Holt, J. T., Stein, R. W., & Moses, H. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3758 · Cited by 398
Lue, R. A., Marfatia, S. M., Branton, D., & Chishti, A. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9818 · Cited by 368
White, A. E., Livanos, E. M., & Tlsty, T. D. (1994) · Genes & Development · doi:10.1101/gad.8.6.666 · Cited by 368
Bargonetti, J., Friedman, P. N., Kern, S. E., Vogelstein, B., & Prives, C. (1991) · Cell · doi:10.1016/0092-8674(91)90560-l · Cited by 367
Mietz, J. A., Unger, T., Huibregtse, J. M., & Howley, P. M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05608.x · Cited by 365
Lee, S. S., Weiss, R. S., & Javier, R. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6670 · Cited by 356
Cheng, S., Schmidt-Grimminger, D. C., Murant, T., Broker, T. R., & Chow, L. T. (1995) · Genes & Development · doi:10.1101/gad.9.19.2335 · Cited by 349
Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome
Cole, S. T., & Danos, O. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90343-3 · Cited by 345
Identification of herpes simplex virus type 1 genes required for origin-dependent DNA synthesis
Wu, C. A., Nelson, N. J., McGeoch, D. J., & Challberg, M. D. (1988) · Journal of Virology · doi:10.1128/jvi.62.2.435-443.1988 · Cited by 326
The polyproline region of p53 is required to activate apoptosis but not growth arrest
Sakamuro, D., Sabbatini, P., White, E., & Prendergast, G. C. (1997) · Oncogene · doi:10.1038/sj.onc.1201263 · Cited by 316
Rankin, S., & Rozengurt, E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42406-9 · Cited by 301
The INK4a/ARF tumor suppressor: one gene—two products—two pathways
Chin, L., Pomerantz, J., & DePinho, R. A. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01236-5 · Cited by 288
p53 and DNA polymerase α compete for binding to SV40 T antigen
Gannon, J. V., & Lane, D. P. (1987) · Nature · doi:10.1038/329456a0 · Cited by 282
Interaction of Papillomavirus E6 Oncoproteins with a Putative Calcium-Binding Protein
Chen, J. J., Reid, C. E., Band, V., & Androphy, E. J. (1995) · Science · doi:10.1126/science.7624774 · Cited by 275
Lechner, M. S., Mack, D. H., Finicle, A. B., Crook, T., Vousden, K. H., & Laimins, L. A. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05375.x · Cited by 273
The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton
Tong, X., & Howley, P. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4412 · Cited by 268
Zehbe, I., Wilander, E., Delius, H., & Tommasino, M. (1998) · PubMed · Cited by 267
The Role of Papillomaviruses in Human Anogenital Cancer
zur Hausen, H., & Schneider, A. (1987) · The Papovaviridae · doi:10.1007/978-1-4757-0584-3_9 · Cited by 265
Smotkin, D., Prokoph, H., & Wettstein, F. O. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1441-1447.1989 · Cited by 263
Control of cell proliferation by Myc
Bouchard, C., Staller, P., & Eilers, M. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01251-3 · Cited by 253
Inhibition of Bak-induced apoptosis by HPV-18 E6
Thomas, M., & Banks, L. (1998) · Oncogene · doi:10.1038/sj.onc.1202223 · Cited by 241
Self-citationWilcock, D., & Lane, D. P. (1991) · Nature · doi:10.1038/349429a0 · Cited by 239
Pan, H., & Griep, A. E. (1995) · Genes & Development · doi:10.1101/gad.9.17.2157 · Cited by 234
Androphy, E. J., Hubbert, N. L., Schiller, J. T., & Lowy, D. R. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb04849.x · Cited by 233
Transcriptional activation by p53 correlates with suppression of growth but not transformation
CROOK, T. (1994) · Cell · doi:10.1016/0092-8674(94)90071-x · Cited by 233
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.775 · Cited by 233
Sedman, S. A., Barbosa, M. S., Vass, W. C., Hubbert, N. L., Haas, J. A., Lowy, D. R., & Schiller, J. T. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.4860-4866.1991 · Cited by 212
Mouse p53 inhibits SV40 origin-dependent DNA replication
Braithwaite, A. W., Sturzbecher, H.-W., Addison, C., Palmer, C., Rudge, K., & Jenkins, J. R. (1987) · Nature · doi:10.1038/329458a0 · Cited by 205
Li, X., & Coffino, P. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4509-4516.1996 · Cited by 201
Detection of novel splicing patterns in a HPV16-containing keratinocyte cell line
Doorbar, J., Parton, A., Hartley, K. O., Banks, L., Crook, T., Stanley, M., & Crawford, L. (1990) · Virology · doi:10.1016/0042-6822(90)90401-c · Cited by 201
Self-citationLeonardo, A. D., Khan, S. H., Linke, S. P., Greco, V., Seidita, G., & Wahl, G. M. (1997) · PubMed · Cited by 198
Masterson, P. J., Stanley, M., Lewis, A. P., & Romanos, M. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7407-7419.1998 · Cited by 196
Inhibition of p53 DNA binding by human papillomavirus E6 proteins
Lechner, M. S., & Laimins, L. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4262-4273.1994 · Cited by 195
Preventing re-replication of DNA in a single cell cycle: evidence for a replication licensing factor
Blow, J. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.5.993 · Cited by 193
p53 codon 72 polymorphism and risk of cervical cancer in UK
Rosenthal, A. N., Ryan, A., Al-Jehani, R. M., Storey, A., Harwood, C. A., & Jacobs, I. J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)07357-7 · Cited by 190
Gao, Q., Srinivasan, S., Boyer, S. N., Wazer, D. E., & Band, V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.733 · Cited by 188
Papillomavirus polypeptides E6 and E7 are zinc-binding proteins
Barbosa, M. S., Lowy, D. R., & Schiller, J. T. (1989) · Journal of Virology · doi:10.1128/jvi.63.3.1404-1407.1989 · Cited by 184
Kühne, C., & Banks, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34302 · Cited by 184
Self-citationHuibregtse, J. M., Scheffner, M., & Howley, P. M. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.8.4918 · Cited by 182
Sedman, J., & Stenlund, A. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00312.x · Cited by 180
Stoppler, M. C., Ching, K. A., Stöppler, H., Clancy, K., Schlegel, R., & Icenogle, J. P. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.6987-6993.1996 · Cited by 177
Gross-Mesilaty, S., Reinstein, E., Bercovich, B., Tobias, K. E., Schwartz, A. L., Kahana, C., & Ciechanover, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8058 · Cited by 177
The dual role model for p53 in maintaining genomic integrity
Janus, F., Albrechtsen, N. J. W., Dornreiter, I., Wiesmüller, L., Große, F., & Deppert, W. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050266 · Cited by 176
Characterization of Human hect Domain Family Members and Their Interaction with UbcH5 and UbcH7
Schwarz, S. E., Rosa, J. L., & Scheffner, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12148 · Cited by 176
Bouvard, V., Storey, A., Pim, D. C., & Banks, L. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06880.x · Cited by 173
Self-citationDefective G2 checkpoint function in cells from individuals with familial cancer syndromes.
Paules, R. S., Levedakou, E. N., Wilson, S. J., Innes, C. L., Rhodes, N., Tlsty, T. D., Galloway, D. A., Donehower, L. A., Tainsky, M. A., & Kaufmann, W. K. (1995) · PubMed · Cited by 169
Thomas, M., & Banks, L. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-6-1513 · Cited by 166
Self-citationHuman Papillomavirus Oncoproteins E6 and E7 Independently Abrogate the Mitotic Spindle Checkpoint
Thomas, J. T., & Laimins, L. A. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1131-1137.1998 · Cited by 162
Foster, S. A., Demers, G. W., Etscheid, B. G., & Galloway, D. A. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5698-5705.1994 · Cited by 160
Schmitt, A., Harry, J. B., Rapp, B., Wettstein, F. O., & Iftner, T. (1994) · Journal of Virology · doi:10.1128/jvi.68.11.7051-7059.1994 · Cited by 156
Doorbar, J., Foo, C., Coleman, N., Medcalf, L., Hartley, O., Prospero, T. D., Napthine, S., Sterling, J. C., Winter, G. P., & Griffin, H. M. (1997) · Virology · doi:10.1006/viro.1997.8768 · Cited by 150
Crook, T., & Vousden, K. H. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05487.x · Cited by 148
Scheffner, M., Takahashi, T., Huibregtse, J. M., Minna, J. D., & Howley, P. M. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.5100-5105.1992 · Cited by 146
Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells
Band, V, De Caprio, J. A., Delmolino, L., Kulesa, V, & Sager, R. (1991) · Journal of Virology · doi:10.1128/jvi.65.12.6671-6676.1991 · Cited by 145
Banks, L., Spence, P., Androphy, E. J., Hubbert, N. L., Matlashewski, G., Murray, A., & Crawford, L. (1987) · Journal of General Virology · doi:10.1099/0022-1317-68-5-1351 · Cited by 145
Self-citationAnalysis of human p53 proteins and mRNA levels in normal and transformed cells
Matlashewski, G., Banks, L., Pim, D., & Crawford, L. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09449.x · Cited by 139
Self-citationPim, D., Massimi, P., & Banks, L. (1997) · Oncogene · doi:10.1038/sj.onc.1201202 · Cited by 136
Self-citationStöppler, H., Hartmann, D.-P., Sherman, L., & Schlegel, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13332 · Cited by 129
Fortunato, E. A., & Spector, D. H. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2033-2039.1998 · Cited by 129
The ubiquitin‐protein ligase E6‐associated protein (E6‐AP) serves as its own substrate
Nuber, U., Schwarz, S. E., & Scheffner, M. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540643.x · Cited by 128
Sherman, L., & Schlegel, R. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3269-3279.1996 · Cited by 126
Human Papillomavirus DNA Replication
Conger, K. L., Liu, J., Kuo, S., Chow, L. T., & Wang, T. S. ‐. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.5.2696 · Cited by 126
The human papillomavirus-16 E6 oncoprotein decreases the vigilance of mitotic checkpoints
Thompson, D. A., Belinsky, G. S., Chang, T. H., Jones, D. L., Schlegel, R., & Münger, K. (1997) · Oncogene · doi:10.1038/sj.onc.1201495 · Cited by 120
Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells
Beer‐Romero, P., Glass, S., & Rolfe, M. (1997) · Oncogene · doi:10.1038/sj.onc.1200872 · Cited by 120
Butz, K., Geisen, C., Ullmann, A., Spitkovsky, D., & Hoppe‐Seyler, F. (1996) · International Journal of Cancer · Cited by 108
Human cytomegalovirus elevates levels of the cellular protein p53 in infected fibroblasts
Muganda, P. M., Mendoza, O., Hernandez, J., & Qian, Q. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8028-8034.1994 · Cited by 101
Elbel, M., Carl, S., Spaderna, S., & Iftner, T. (1997) · Virology · doi:10.1006/viro.1997.8860 · Cited by 97
A direct effect of activated human p53 on nuclear DNA replication.
Cox, L. S., Hupp, T. R., Midgley, C., & Lane, D. P. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07201.x · Cited by 90
Filatov, L. V., Golubovskaya, V., Hurt, J. C., Byrd, L. L., Phillips, J. M., & Kaufmann, W. K. (1998) · Oncogene · doi:10.1038/sj.onc.1201711 · Cited by 88
Cai, Z., Métay, C., Moyret‐Lalle, C., Amor-Guéret, M., Feunteun, J., Larsen, A. K., Paillerets, B. B., & Chouaı̈b, S. (1997) · Oncogene · doi:10.1038/sj.onc.1201445 · Cited by 86
Xiong, Y., Kuppuswamy, D., Li, Y., Livanos, E., Hixon, M. L., White, A., Beach, D., & Tlsty, T. D. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.999-1008.1996 · Cited by 84
Huang, P. (1998) · Oncogene · doi:10.1038/sj.onc.1201946 · Cited by 81
Kanda, T., Watanabe, S., Zanma, S., Sato, H., Furuno, A., & Yoshiike, K. (1991) · Virology · doi:10.1016/0042-6822(91)90523-e · Cited by 76
Deau, M.-C., Fãvre, M., & Orth, G. (1991) · Virology · doi:10.1016/0042-6822(91)90419-c · Cited by 74
Remm, M., Brain, R., & Jenkins, J. R. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.22.6015 · Cited by 68
Nakagawa, S., Watanabe, S., Yoshikawa, H., Taketani, Y., Yoshiike, K., & Kanda, T. (1995) · Virology · doi:10.1006/viro.1995.1511 · Cited by 67
Stacey, S., Jordan, D., Snijders, P. J. F., Mackett, M., Walboomers, J. M. M., & Arrand, J. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.7023-7031.1995 · Cited by 66
Janus, F., Albrechtsen, N., Knippschild, U., Wiesmüller, L., Große, F., & Deppert, W. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.2155 · Cited by 62
Steller, M. A., Zou, Z., Schiller, J. T., & Baserga, R. (1996) · PubMed · Cited by 59
Kiyono, T., Hiraiwa, A., Ishii, S., Takahashi, T., & Ishibashi, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4656-4661.1994 · Cited by 58
Burnett, A., Barnes, W. A., Johnson, J. C., Grendys, E. C., Willett, G. D., BARTER, J. F., & Doniger, J. (1992) · Gynecologic Oncology · doi:10.1016/0090-8258(92)90137-8 · Cited by 51
p53 Protein Is a Suppressor of Papillomavirus DNA Amplificational Replication
Lepik, D., Ilves, I., Kristjuhan, A., Maimets, T., & Ustav, M. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6822-6831.1998 · Cited by 49
Rougui, Z., Bouizar, Z., Walrant-Debray, O., & Rizk‐Rabin, M. (1998) · Endocrinology · doi:10.1210/endo.139.4.5903 · Cited by 49
p53 Inhibits DNA Replication In Vitro in a DNA-Binding-Dependent Manner
Miller, S. D., Farmer, G., & Prives, C. L. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6554 · Cited by 42
Expression of human papillomavirus type 16 E7 gene induces DNA synthesis of rat 3Y1 cells
Sato, H., Furuno, A., & Yoshiike, K. (1989) · Virology · doi:10.1016/0042-6822(89)90423-6 · Cited by 40
Imai, T., Matsuda, K., Shimojima, T., Hashimoto, T., Masuhiro, Y., Kitamoto, T., Sugita, A., Suzuki, K., Matsumoto, H., Masushige, S., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6531 · Cited by 38
Shally, M., Alloul, N., Jackman, A., Müller, M., Gissmann, L., & Sherman, L. (1996) · Virus Research · doi:10.1016/0168-1702(96)01301-9 · Cited by 27
Stimulation of Polyomavirus DNA Replication by Wild-Type p53 Through the DNA-Binding Site
Kanda, T., Segawa, K., Ohuchi, N., Mori, S., & Ito, Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2651 · Cited by 27
Associations between Oncogenic Human Papillomaviruses and Local Invasive Patterns in Cervical Cancer
Zhang, J., Rose, B. R., Thompson, C. H., Jarrett, C. S., Russell, P., Houghton, R. S., & Cossart, Y. E. (1995) · Gynecologic Oncology · doi:10.1006/gyno.1995.1120 · Cited by 24
Muganda, P. M., Carrasco, R. D., & Qian, Q. (1998) · PubMed · Cited by 23
Gardiol, D., & Banks, L. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-8-1963 · Cited by 22
Self-citationIshiwatari, H., Hayasaka, H., Inoue, H., Yutsudo, M., & Hakura, A. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890440306 · Cited by 19
Inoue, T., Oka, K., Hwang, Y.-I., Vousden, K. H., Kyo, S., Jing, P., Hakura, A., & Yutsudo, M. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199803)21:3<215::aid-mc9>3.0.co;2-k · Cited by 17
Cited by
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
“Unlike in many other cancers, the p53 in cervical cancer is usually wild type and is not mutated (116).”
InfluentialChapter 1: HPV in the etiology of human cancer
Muñoz, N., Castellsagué, X., de González, A. B., & Gissmann, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.115 · Cited by 1,355
“nscheduled S-phase would normally lead to apoptosis by he action of p53; however, in HPV-infected cells, this proess is counteracted by the viral E6 protein, which targets 53 for proteolytic degradation [5].”
BackgroundThe oralome and its dysbiosis: New insights into oral microbiome-host interactions
Radaic, A., & Kapila, Y. L. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.02.010 · Cited by 467
HPV‐mediated cervical carcinogenesis: concepts and clinical implications
Snijders, P. J., Steenbergen, R. D., Heideman, D. A., & Meijer, C. J. (2006) · The Journal of Pathology · doi:10.1002/path.1866 · Cited by 455
Jiang, M., & Milner, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205878 · Cited by 369
Metadata
- Authors
- Thomas, M., Pim, D., & Banks, L.
- Venue
- Oncogene
- Published
- 1999-12-13
- Volume
- 18
- Issue
- 53
- Pages
- 7690-7700
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1965806742
- Cited by
- 451
- References
- 130
- FWCI
- 9.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.